108 related articles for article (PubMed ID: 1376384)
1. B-cell subsets and platelet counts in HIV-1 seropositive subjects.
Kouri YH; Basch RS; Karpatkin S
Lancet; 1992 Jun; 339(8807):1445-6. PubMed ID: 1376384
[TBL] [Abstract][Full Text] [Related]
2. CD5+ B lymphocytes in HIV infection: relationship to immunological progression of disease.
Sampalo A; López-Gómez M; Jiménez-Alonso J; Ortiz F; Samaniego F; Garrido F
Clin Immunol Immunopathol; 1993 Mar; 66(3):260-8. PubMed ID: 7679344
[TBL] [Abstract][Full Text] [Related]
3. The relationship between CD5+ and CD5- B cells, immunoglobulin-secreting cells (IgSC), and CD4 T cells in human immunodeficiency virus (HIV) infection.
Spira TJ; Jones B; Ibegbu C; Lee F; Holmes R; Nahmias AJ
Ann N Y Acad Sci; 1992 May; 651():591-3. PubMed ID: 1376087
[No Abstract] [Full Text] [Related]
4. [CD5+B cells and autoimmune diseases].
Yu JR; Qiu ZX; Yang H
Zhonghua Nei Ke Za Zhi; 1994 Sep; 33(9):590-2. PubMed ID: 7536147
[TBL] [Abstract][Full Text] [Related]
5. Immunologic thrombocytopenic purpura in human immunodeficiency virus--seropositive patients with hemophilia. Comparison with patients with classic autoimmune thrombocytopenic purpura, homosexuals with thrombocytopenia, and narcotic addicts with thrombocytopenia.
Karpatkin S; Nardi MA
J Lab Clin Med; 1988 Apr; 111(4):441-8. PubMed ID: 3258345
[TBL] [Abstract][Full Text] [Related]
6. B cells expressing CD5 antigen are markedly increased in peripheral blood and spleen lymphocytes from patients with immune thrombocytopenic purpura.
Mizutani H; Furubayashi T; Kashiwagi H; Honda S; Take H; Kurata Y; Yonezawa T; Tarui S
Br J Haematol; 1991 Aug; 78(4):474-9. PubMed ID: 1716955
[TBL] [Abstract][Full Text] [Related]
7. Sequestration of anti-platelet GPIIIa antibody in rheumatoid factor immune complexes of human immunodeficiency virus 1 thrombocytopenic patients.
Karpatkin S; Nardi MA; Hymes KB
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2263-7. PubMed ID: 7892259
[TBL] [Abstract][Full Text] [Related]
8. B cell activation and human immunodeficiency virus infection. V. Phenotypic and functional alterations in CD5+ and CD5- B cell subsets.
Indraccolo S; Mion M; Zamarchi R; Veronesi A; Veronese ML; Panozzo M; Betterle C; Barelli A; Borri A; Amadori A
J Clin Immunol; 1993 Nov; 13(6):381-8. PubMed ID: 7507125
[TBL] [Abstract][Full Text] [Related]
9. Anti-phospholipid antibodies and CD5+ B cells in HIV infection.
Grünewald T; Burmester GR; Schüler-Maué W; Hiepe F; Buttgereit F
Clin Exp Immunol; 1999 Mar; 115(3):464-71. PubMed ID: 10193419
[TBL] [Abstract][Full Text] [Related]
10. Identification of a CD21 receptor-deficient, non-Ig-secreting peripheral B lymphocyte subset in HIV-seropositive drug abusers.
Benedetto A; Di Caro A; Camporiondo MP; Gallone D; Zaniratti S; Tozzi V; Elia G
Clin Immunol Immunopathol; 1992 Feb; 62(2):139-47. PubMed ID: 1370396
[TBL] [Abstract][Full Text] [Related]
11. Serial study of CD5+ and CD5- B cell subpopulations in 335 HIV seropositive patients.
Vuillier F; Scott-Algara D; Tortevoye P; Pialoux G; Dighiero G
Clin Exp Immunol; 1991 Sep; 85(3):476-80. PubMed ID: 1716542
[TBL] [Abstract][Full Text] [Related]
12. The effect of combination antiretroviral therapy on CD5 B- cells, B-cell activation and hypergammaglobulinaemia in HIV-1-infected patients.
Redgrave BE; Stone SF; French MA; Krueger R; James IR; Price P
HIV Med; 2005 Sep; 6(5):307-12. PubMed ID: 16156877
[TBL] [Abstract][Full Text] [Related]
13. Frequency and prognostic importance of thrombocytopenia in symptom-free HIV-infected individuals: a 5-year prospective study.
Peltier JY; Lambin P; Doinel C; Couroucé AM; Rouger P; Lefrére JJ
AIDS; 1991 Apr; 5(4):381-4. PubMed ID: 1676281
[TBL] [Abstract][Full Text] [Related]
14. Aberrant T-regulation in rheumatoid arthritis and IgA nephropathy affects CD5+ and CD5- B lymphocytes equally.
Jones BM; Cheng IK; Wong RW
Clin Exp Immunol; 1991 Nov; 86(2):212-8. PubMed ID: 1718638
[TBL] [Abstract][Full Text] [Related]
15. CD5 positive B lymphocytes in schizophrenia: no alteration in numbers or percentage as compared with control subjects.
Ganguli R; Rabin BS
Psychiatry Res; 1993 Jul; 48(1):69-78. PubMed ID: 7692460
[TBL] [Abstract][Full Text] [Related]
16. The elevation of circulating platelets after IFN-alpha therapy in HIV-1 seropositive thrombocytopenic patients correlates with increased plasma levels of IL-6.
Zauli G; Re MC; Gugliotta L; Furlini G; La Placa M
New Microbiol; 1993 Jan; 16(1):27-34. PubMed ID: 8469169
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD5 and CD72 on T and B cell subsets in rheumatoid arthritis and Sjögren's syndrome.
Jamin C; Lamour A; Pennec YL; Hirn M; Le Goff P; Youinou P
Clin Exp Immunol; 1993 May; 92(2):245-50. PubMed ID: 7683586
[TBL] [Abstract][Full Text] [Related]
18. Increased CD5-positive B lymphocytes in type I diabetes.
Muñoz A; Gallart T; Viñas O; Gomis R
Clin Exp Immunol; 1991 Feb; 83(2):304-8. PubMed ID: 1704297
[TBL] [Abstract][Full Text] [Related]
19. CD5+ B cells are decreased in peripheral blood of patients with Crohn's disease.
Neil GA; Summers RW; Cheyne BA; Capenter C; Huang WL; Kansas GS; Waldschmidt TJ
Dig Dis Sci; 1992 Sep; 37(9):1390-5. PubMed ID: 1380423
[TBL] [Abstract][Full Text] [Related]
20. CD5+ B lymphocytes and T-cell subsets in a case of juvenile rheumatoid arthritis.
Ambrogi F; Ricciardi L; Nutini P; Vanacore R
Ann N Y Acad Sci; 1992 May; 651():564-9. PubMed ID: 1376077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
